BALYASNY ASSET MANAGEMENT L.P. Horizon Therapeutics Public Limited Company Transaction History

BALYASNY ASSET MANAGEMENT L.P. portfolio value:

$866,000
portfolio value

Horizon Therapeutics Public Limited Company 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 1.16M shares 72.01M $61.89 1.16M
Q3 2022 put Increase 0.00% 4K shares 248K $61.89 4K
Q3 2022 call Increase 0.00% 14K shares 866K $61.89 14K
Q3 2021 share Decrease -100.00% -366.37K shares -34.30M $109.54 0
Q2 2021 share Increase +451.82% 299.97K shares 28.19M $93.64 366.37K
Q1 2021 share Increase 0.00% 66.39K shares 6.11M $92.04 66.39K
Q4 2020 share Decrease -100.00% -178.63K shares -13.87M $73.15 0
Q3 2020 share Increase +221.33% 123.04K shares 10.78M $77.68 178.63K
Q2 2020 share Decrease -88.10% -411.65K shares -10.75M $55.58 55.59K
Q1 2020 share Decrease -51.09% -488.02K shares -20.74M $29.62 467.24K
Q4 2019 share Increase +241.86% 675.84K shares 26.97M $36.2 955.27K
Q3 2019 put Decrease -100.00% -200K shares -4.75M $27.23 0
Q3 2019 share Decrease -67.12% -570.56K shares -12.84M $27.23 279.43K
Q2 2019 put Increase 0.00% 200K shares 4.75M $24.06 200K
Q2 2019 share Increase 0.00% 849.99K shares 20.45M $24.06 849.99K